NCT04935021View on ClinicalTrials.gov

Clinical Study of ATTR-CM

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 1, 2031

Study Completion Date

June 1, 2031

Conditions
Transthyroxine Amyloidosis Cardiomyopathy
Interventions
DRUG

ATTR-CM

Current treatment

Trial Locations (1)

Unknown

RECRUITING

xiaohong University PAN, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER